The effect of service screening on breast cancer mortality rates

European Journal of Cancer Prevention

Volumn 17, Issue 4, 2008, Pages 306-311

  Cox, Brian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Breast screening; Effectiveness; Monitoring; Simulation

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; AGE; BREAST TUMOR; CAUSE OF DEATH; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; EVALUATION; HEALTH SURVEY; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MORTALITY; NEW ZEALAND; PUBLIC HEALTH; RISK FACTOR; STATISTICS; SURVIVAL; THEORETICAL MODEL;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CAUSE OF DEATH; COST-BENEFIT ANALYSIS; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, THEORETICAL; MORTALITY; NATIONAL HEALTH PROGRAMS; NEW ZEALAND; POPULATION SURVEILLANCE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 49649128189     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3282f0c0cc     Document Type: Article

References (18)

1. Andersson I, Janzon L (1997). Reduced breast cancer mortality in women under age 50: updated results from the Malmo mammographic screening program. J Natl Cancer Inst Monogr 22:63-67.
2. Ballard-Barbash R, Klabunde C, Paci E, Broeders M, Coleman E, Fracheboud J, et al. (1999). Breast cancer screening in 21 countries: delivery of services, notification of results and outcomes ascertainment. Eur J Cancer Prev 8:417-426.
3. Beckett JR, Kotre CJ, Michaelson JS (2003). Analysis of benefit: risk ratio and mortality reduction for the UK Breast Screening Programme. Br J Radiol 76:309-320.
4. Bennet RL, Blanks R, Moss S, Roche MF (2006). The effect of data quality at the time of introduction of population-based screening on the estimate of programme impact using surrogate outcome measures. J Med Screen 13:197-200.
5. Bjurstam N, Bjorneld L, Duffy S, Smith T, Cahlin E, Eriksson O, et al.; National Institutes of Health Consensus Development Panel (1997). The Gothenburg breast screening trial: first results on mortality, incidence and mode of detection for women ages 39-49 years at randomization. Cancer 80: 2091-2099.
6. BreastScreen Aotearoa Independent Monitoring Group (2002). BreastScreen Aotearoa: December 1998 to December 2000. In Technical Report No. 33. Hugh Adam Cancer Epidemiology Unit, Department of Preventive and Social Medicine, University of Otago: Dunedin.
7. Cox B (1997). Variation in the effectiveness of breast screening by year of followup. J Natl Cancer Inst Monogr 22:69-72.
8. Hakama M, Pukkala E, Heikkila M, Kallio M (1997). Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. Br Med J 314:864-867.
9. International Agency for Research on Cancer (2002). Breast cancer screening. IARC handbooks of cancer prevention. Vol. 7. Lyon, France: IARC Press Publications.
10. Moss S, Cuckle H, Evans A, Johns L, Waller M, Bobrow L, Trial Management Group (2006). Effect of mammographic screening from the age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 368:2053-2060.
11. New Zealand Health Information Service (2003). Mortality and demographic data 1999. Wellington: Ministry of Health. pp. 1-160.
12. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist L (2002). Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359:909-919.
13. Richardson A, Graham P, Brown T, Smale P, Cox B (2004). Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme. J Med Screen 11: 65-69.
14. Shapiro S (1997). Periodic screening for breast cancer: the HIP randomized controlled trial. J Nat Cancer Inst Monogr 22:22-27.
15. Shapiro S, Coleman E, Broeders M, Codd M, de Koning H, Fracheboud J, et al.; International Breast Cancer Screening Network and the European Network of Pilot Projects for Breast Cancer Screening (1998). Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 27:735-742.
16. Tabar L, Fagerberg G, Chen H-H, Duffy S, Smart C, Gad A, Smith R (1995). Efficacy of breast cancer screening by age: new results from the Swedish two-country trial. Cancer 75:2507-2517.
17. Writing Group for the Women's Health Initiative Investigators (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Association 288:321-333.
18. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP (2006). Rate of overdiagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study. Br Med J 10:1-4.